ProfileGDS5822 / ILMN_2623844
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 92% 96% 96% 92% 97% 95% 97% 95% 93% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1704.492
GSM1276600PDAC Late Ablation Control 21552.796
GSM1276601PDAC Late Ablation Control 31561.496
GSM1276602PDAC Late Ablation 1681.592
GSM1276603PDAC Late Ablation 22349.997
GSM1276604PDAC Late Ablation 31377.695
GSM1303940PDAC Late Ablation_anti-CTLA4 1177897
GSM1303941PDAC Late Ablation_anti-CTLA4 21358.195
GSM1303942PDAC Late Ablation_anti-CTLA4 3904.293